Prime Medicine (PRME) Insider Trading & Ownership $6.16 -0.02 (-0.32%) As of 09:34 AM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Prime Medicine (NASDAQ:PRME) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage22.74%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$20.40MNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$6.08M Get PRME Insider Trade Alerts Want to know when executives and insiders are buying or selling Prime Medicine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRME Insider Buying and Selling by Quarter Prime Medicine Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/19/20232019 Gp L.L.C. GvMajor ShareholderSell63,212$13.88$877,382.56 5/17/20232019 Gp L.L.C. GvMajor ShareholderSell15,000$12.77$191,550.00 5/15/20232019 Gp L.L.C. GvMajor ShareholderSell157,952$12.74$2,012,308.48 5/12/20232019 Gp L.L.C. GvMajor ShareholderSell27,290$12.72$347,128.80 5/10/20232019 Gp L.L.C. GvMajor ShareholderSell87,397$14.03$1,226,179.91 5/8/20232019 Gp L.L.C. GvMajor ShareholderSell100,772$14.13$1,423,908.36 10/24/20222019 Gp L.L.C. GvMajor ShareholderBuy800,000$17.00$13,600,000.00 10/24/2022Thomas CahillDirectorBuy400,000$17.00$6,800,000.00 (Data available from 1/1/2013 forward) PRME Insider Trading Activity - Frequently Asked Questions Who is on Prime Medicine's Insider Roster? The list of insiders at Prime Medicine includes 2019 Gp L.L.C. Gv, and Thomas Cahill. Learn more on insiders at PRME. What percentage of Prime Medicine stock is owned by insiders? 22.74% of Prime Medicine stock is owned by insiders. Learn more on PRME's insider holdings. More Insider Trading Tools from MarketBeat Related Companies Xenon Pharmaceuticals Insider Trading Gemini Therapeutics Insider Trading Scholar Rock Insider Trading Ultragenyx Pharmaceutical Insider Trading AMNEAL PHARMACEUTICALS Insider Trading Immunovant Insider Trading Centessa Pharmaceuticals Insider Trading Tarsus Pharmaceuticals Insider Trading Apellis Pharmaceuticals Insider Trading Mineralys Therapeutics Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Healthcare Companies Insiders Are Buying Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's ComebackInsider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t Worry This page (NASDAQ:PRME) was last updated on 10/21/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prime Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Prime Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
